Cuba vs Hungary: Cause of death, by non-communicable diseases, ages 0-4, female
Cuba
39.2%
in 2021
Hungary
39.4%
in 2021
Cuba rank
52nd
Hungary rank
50th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Cuba
- Hungary
How they compare
Hungary currently reports 39.4% against 39.2% in Cuba, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Cuba ahead.
Cuba ranks 52nd and Hungary ranks 50th of 185 countries.
Across the 3 decades both report, Cuba averaged higher in 1 and Hungary in 2.
Head to head by decade
| Decade | Cuba | Hungary | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.8% | 32.1% | 9.7% | Cuba |
| 2010s | 39.8% | 39.9% | 0.1% | Hungary |
| 2020s | 38.6% | 40.0% | 1.4% | Hungary |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Cuba or Hungary?
- Hungary, at 39.4% against 39.2% in Cuba as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Cuba and Hungary?
- 0.2%, with Hungary ahead.
- How many years of comparable data are there for Cuba and Hungary?
- 6 years are reported by both, from 2000 to 2021.
- How do Cuba and Hungary rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Cuba ranks 52nd and Hungary ranks 50th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.